Publications by authors named "Rumeysa Colak"

Claim this Profile
B
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
Sinem Akbas, Ozkan Alan, Oguzhan Yildiz, Melek Karakurt, Eda Caliskan Yildirim, Rumeysa Colak

J Neurooncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer.
Alper Turkel, Ece Baydar, Rümeysa Çolak, Ahmet Emin Öztürk, Teoman Şakalar

In Vivo· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response with trastuzumab in heavily pretreated HER2-positive metastatic salivary duct carcinoma.
Rumeysa Çolak, Caner Kapar, Mesut Yilmaz

Anticancer Drugs· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
Selin Akturk Esen, Ismet Seven, Gonca Akdere Ates, Rumeysa Colak, Oğuzcan Kinikoglu

Anticancer Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study.
Serhat Sekmek, Aysel Oguz, Melek Karakurt Eryilmaz, Murat Araz, Sedat Biter, Rumeysa Colak

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.
Mehmet Cem Fidan, Ahmet Emin Öztürk, Okan Aydın, Goncagül Akdağ, Ezgi Türkoğlu

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy.
Rumeysa Colak, Caner Kapar, Ezgi Degerli, Seher Yildiz Tacar, Aysegul Akdogan Gemici

Medicina (Kaunas)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in the neutrophil-lymphocyte ratio may predict early recurrence in operated bladder cancer.
Rumeysa Çolak, Gökmen Umut Erdem, Caner Kapar, İlkay Gültürk, Faruk Aksu

Asia Pac J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab.
Rumeysa Çolak, İlkay Gültürk, Gülhan Dinç, Goncagül Akdağ, Sedat Yıldırım

J Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors.
Murad Guliyev, Ali Kaan Güren, Emre Özge, Rumeysa Çolak, Nargiz Majidova

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4-6 inhibitors?
Ilkay Gültürk, Rumeysa Colak, Caner Kapar, Murad Guliyev, Cigdem Yıldırım

Breast· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy.
Ezgi Değerli, Çağatay Arslan, Fatih Selçukbiricik, Ömer Fatih Ölmez, Dilek Erdem

Medicina (Kaunas)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
Arif Akyildiz, Melis Gultekin, Ecem Yigit, Ecem Demir, Rashad Ismayilov, Rumeysa Colak

Int J Gynecol Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy.
Rumeysa Colak, Caner Kapar, Ilkay Gulturk, Mesut Yilmaz

J Oncol Pharm Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
Muhammet Ozer, Goksel Bengi, Rumeysa Colak, Ozan Cengiz, Hale Akpinar

Medicine (Baltimore)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis